DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Quinagolide
Quinagolide
Hyperprolactinaemia: a Monster Between the Woman and Her Conception *Seriki A
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Stereotactic Radiosurgery for Pituitary Tumors
Guidance on the Treatment of Antipsychotic Induced Hyperprolactinaemia in Adults
POISONS LIST APPENDIX Amoebicides: Carbarsone
Summary of Product Characteristics
Pharmacotherapy for Stimulant Use Disorders: a Systematic Review
Pharmacological Aspects and Potential New Clinical Applications of Taurine and Bromocriptine
Centre for Reviews and Dissemination
( 12 ) United States Patent
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Benign Intracranial Hypertension Associated with the Withdrawal of a Non-Ergot Dopamine Agonist
Cabergoline and the Risk of Valvular Lesions in Endocrine Disease
Medical Treatment of Prolactinomas Annamaria Colao and Silvia Savastano
Marleen BW.Indd
Hyperprolactinemia
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Poisons Standard February 2020
Top View
Preclinical and Clinical Experiences with the Role of Dopamine Receptors in the Treatment of Pituitary Adenomas
Product Information
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
View the PDF Document
Dopamine Dopamine Serotonin Lisuride
QUINAGOLIDE SUMMARY SHEET TRADE NAME: Norprolac Licensed
Psychological Effects of Dopamine Agonist Treatment in Patients With
Chapter 1: Hyperprolactinemia and Woman's Health
Comparative Analyses of Semen and Endocrine Characteristics of Free-Living Versus Captive Jaguars (Panthera Onca)
Prolactin Secretion in Women: Narrative Review
Draft Package Insert
ESE Clinical Practice Guideline on Functioning and Nonfunctioning Pituitary Adenomas in Pregnancy
Solutions Your Api Intermediates
An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
Withdrawal of Medical Therapy in Prolactinomas
Adverse Drug Reactions to Dopamine Agonists: a Comparative Study in the French Pharmacovigilance Database
Contemporary Management of Prolactinomas
Cabergoline Or Quinagolide Versus Bromocriptine for Hyperprolactinemia with Or Without Prolactinoma: Clinical Effectiveness, Cost- Effectiveness, and Guidelines
Cabergoline Versus Quinagolide for the Management of Macroprolactinoma and Erectile Dysfunction: a Randomized, Open-Label Study
Hyperprolactinemia: a Systematic Review of Diagnosis and Management Nazma Akter1, Nazmul Kabir Qureshi2, Tangera Akter3
3527347852 Bindex.Pdf
Drug Repurposing Compound Library Plus (96-Well)
Comparison of the Effects of Cabergoline and Bromocriptine in Women with Hyperprolactinemic Amenorrhea
Drugs Formulary
Increased Prevalence of Subclinical Cardiac Valve Fibrosis in Patients with Prolactinomas on Long-Term Bromocriptine and Cabergo
Principali Interazioni Dei Farmaci Onco-Ematologici Con Farmaci, Fitoterapici Ed Alimenti
Downloaded From
Drug Repurposing Compound Library (96-Well)
Hyperprolactinemia (1 of 9)
For Continued Specialist Prescribing AMBER
Dopaminergic Substances and Sudden Sleep Onset
The Effect of Quinagolide and Cabergoline, Two Selective Dopamine Receptor Type 2 Agonists, in the Treatment of Prolactinomas
Pharmacological Aspects and Potential New Clinical Applications of Taurine and Bromocriptine
Guidance on the Use of Antipsychotics
Lääkeluettelon Aineet, Liite 1
Dopamine Agonists: Pathological Gambling and Increased Libido
Contraceptive Options for Women with Prolactinoma September 2012
WO 2016/100940 Al ©O